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Figure 1. Upper panels: TEM micrographs and schematics of actin-hosting
DNA track building blocks. Bottom: TEM micrograph of a synthetic filament
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Prostate apoptosis response-4 (Par-4) is a protein that has primarily been con-
nected with apoptotic processes. Recently, we have shown that Par-4 also plays
a role in smooth muscle contractility. Here, we have tested the hypothesis that
Par-4 regulates the phosphorylation state of myosin regulatory light chain
(LC20) by modulating the activity of myosin phosphatase. In the smooth mus-
cle-derived cell line A7r5, Par-4 colocalizes with the targeting (MYPT1) and
catalytic (PP1cd) subunits of myosin phosphatase on actin filaments. Proximity
ligation assays demonstrate a close proximity of Par-4 and MYPT1 in vivo.
Moreover, endogenous MYPT1 and PP1cd co-immunoprecipitate with endog-
enous Par-4 from A7r5 lysates. Direct binding of Par-4 and MYPT1 is shown
by surface plasmon resonance, and the leucine zipper of MYPT1 is required for
direct binding. The domain of Par-4 that mediates interaction with MYPT1 has
been mapped to the leucine zipper motif in co-immunoprecipitation experi-
ments and in proximity ligation assays. LC20 phosphorylation assays using
the proximity ligation assay revealed that overexpression of Par-4 and a phos-
phorylation site mutant of Par-4 (T155A), but not a leucine-zipper defective
mutant (L3A), leads to reduced phosphorylation levels of LC20, suggesting ac-
tivation of myosin phosphatase by Par-4 in a leucine-zipper dependent manner.
Moreover, the co-expression of either Par-4 mutant, but not wild type Par-4,
with zipper-interacting protein kinase (ZIPK) interferes with ZIPK mediated
LC20 phosphorylation. Our results demonstrate that Par-4 interacts with sub-
units of the myosin phosphatase in vivo, possibly as an accessory protein
that supports the catalytic activity of myosin phosphatase by an as yet unknown
mechanism. At the same time, Par-4 is required for efficient inhibition of my-
osin phosphatase by ZIPK. Support: HL31704, HL80003, HL86655, AR41637
from the NIH, AHA postdoctoral fellowship to SV.
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Our current knowledge on the ultrastructure of smooth muscle (SM) cells does
not satisfactorily account for the particular length-tension behavior of SM,
which seems to be able to adapt its contractile apparatus to generate great force
over a wide range of lengths. A key question in the field remains: Are contrac-
tile filaments in SM cells a fixed array or dynamic structures? There is insuffi-
cient knowledge as to whether the myosin filaments can indeed reorganize
themselves in vivo as has been shown through proposed models. We are pro-
posing here to develop a microinjection technique to address this question.
Methods: Smoothmuscle myosin was purified from chicken gizzard using serial
precipitation. As a control, monomeric myosin and self-assembled filaments of
the purifiedmyosin were tested for functionality using an in vitro motility assay.
The myosin was then labeled with a rhodamine-derivative fluorophore, tetra-
methylrhodamine-5-iodoacetamide dihydroiodide (5-TMRIA). The labeledmy-
osin was then self-assembled in vitro into filaments and images were taken using
a spinning-disk confocal microscope. The labeled filaments, as well as mono-
meric myosin were then respectively microinjected into cultured A5R7 vascular
SM cells. The volume of the cells was estimated bymeasuring them using a cali-
bratedmicroscopic ruler. The volume of myosin solution that was microinjected
represented 2 to 5% of the estimated volume of the cells. The cells’ viability was
estimated by observing their morphology after the microinjection.
Results: The purified myosin was functional in the in vitro motility assay, both
in a monomeric and filamentous form. The microinjection technique could be
done with little modifications of the morphology of the injected cells in a rea-
sonable number of cells.
Conclusion: The microinjection technique of purified myosin can be used for
further studies on the ultrastructure and dynamics of myosin filaments in
smooth muscle cells.
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University of Vermont, Burlington, VT, USA.A feature of most class V myosins is their ability to move processively on actin.
The budding yeast Saccharomyces cerevisiae has a non-processive class Vmyo-
sin,Myo4p,which is a single-headed but high duty cyclemotor. Its cellular role is
to asymmetrically transport more than 20 different mRNAs, a widely used strat-
egy to polarize a protein within the cell. Themost studiedmRNA isASH1, which
ismoved byMyo4p to the bud tip to repressmating type switching in the daughter
cell. Here we determine the features of Myo4p that are necessary for correct lo-
calization of ASH1mRNA to the daughter cell. This process requires the adapter
protein She3p, and the mRNA binding protein She2p, which binds ASH1 at spe-
cific localization elements called zip codes. Based on a series of chimeric con-
structs, we showed that the rod region of Myo4p, but not the globular tail, is es-
sential for correct localization ofASH1mRNA.The rod thus contains the primary
binding site for She3p, consistent with our earlier in vitro studies (Hodges et al.,
2008). To test if mRNA localization is more efficient when two motors are cou-
pled together, we compared transport by a constitutive dimer of Myo4p/She3p
with a constitutive monomer. Correct ASH1 mRNA localization was achieved
equally well with both constructs. This may reflect the fact that many mRNAs
and thus many motors are part of the translocation complex. Our results show
that themost important feature for correct localization is the retention of coupling
between all the members of the complex (Myo4p- She3p-She2p-ASH1mRNA),
which is aided by She3p being a tightly bound subunit of Myo4p.
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An important part of cellular transportation infrastructure is formed by myosin
motors that use actin filaments as their tracks. Many questions concerning the
mechano-chemistry of those motors and the degree of evolutionary adaption to
the track topology remain elusive because we cannot tailor the geometric prop-
erties of F-actin.
Here, we employ three-dimensional DNA origami to construct hybrid DNA-ac-
tin filaments with precisely controlled geometric properties. We engineered
building blocks exhibiting custom-shaped cavities that host F-actin tetramers
such thatmyosinmotorsmay still access their usual binding site on actin.We de-
scribe triggering the formation of filaments from those building blocks that grow
to lengths above 10 microns and that have periodically aligned cavities for host-
ing actin segments. Binding-site orientation can be rotated by 90 degrees with
respect to the filament axis to probe myosin’s ability to take sidesteps. We pro-
pose the following strategy for hosting actin fragments: F-actin is labeled with
thiol-modified oligos, followed by capture of this oligo by the DNA track build-
ing blocks, followed by filament bending into the custom shaped cavity on each
building block, followed by filament breaking fueled by DNA hybridization.669-Pos Board B548
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The availability of quantitative experimental data on the kinetics of actin as-
sembly has enabled the construction of many mathematical models focused
on explaining specific behaviors of this complex system. However these ad
hoc models are generally not reusable or accessible by the large community
of actin biologists. In this work, we present a comprehensive model that inte-
grates and unifies much of the in vitro data on the components of the dendritic
nucleation mechanism for actin dynamics. Over 300 simulations have been run
based on compartmental and 3D spatial versions of this model. We have exam-
ined the behavior of the overall system as a function of the concentrations of
actin, capping protein, thymosin-ß4, profilin and ADF/cofilin. We are able to
provide an explanation for the sharp boundary between actin assembly and
with periodically spaced actin hosting cavities.
